Hypertension after renal transplantation

Pediatric Nephrology

Volumn 24, Issue 5, 2009, Pages 959-972

  Seeman, Tomáá ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Angiotensin converting enzyme inhibitors; Blood pressure control; Children; Graft function; Graft survival; Hypertension; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; NIFEDIPINE; STEROID; TACROLIMUS; THIAZIDE DIURETIC AGENT;

ACUTE GRAFT REJECTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CADAVER DONOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD CARE; CHRONIC ALLOGRAFT NEPHROPATHY; DRUG SAFETY; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; OBESITY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK FACTOR; SIDE EFFECT; SODIUM RETENTION; SURVIVAL RATE; WEIGHT GAIN;

ALGORITHMS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 63649119915     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0627-7     Document Type: Article

References (90)

1. Midtvedt K, Neumayer HH (2000) Management strategies for posttransplant hypertension. Transplantation 70(Suppl 11):SS64-SS69
2. Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A (1994) Analysis of hypertension in children post renal transplantation - a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 8:570-573
3. Sorof JM, Sullivan EK, Tejani A, Portman RJ (1999) Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol 10:1324-1330
4. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158-165
5. Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RSC, Geddes CC, Jardine AG (2005) Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 19:181-192
6. Opelz G, Wujciak T, Ritz E; Collaborative Transplant Study (1998) Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217-222
7. Mange KC, Gizman B, Joffe M, Feldman HI (2000) Arterial hypertension and renal allograft survival. JAMA 283:633-638
8. Schwenger V, Zeier M, Ritz E (2001) Hypertension after renal transplantation. Curr Hypertens Rep 5:434-439
9. Mitsnefes MM, Omoloja A, McEnery PT (2001) Short-term pediatric renal transplant survival: Blood pressure and allograft function. Pediatr Transplant 5:160-165
10. Mitsnefes MM, Khoury PR, McEnery PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98-103
11. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
12. Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni G, Alpert B (1998) Hypertension in young patients after renal transplantation, ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens 11:497-501
13. Mitsnefes MM, Portman RJ (2003) Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant 7:86-92
14. Ferraris JR, Ghezzi L, Waisman G, Krmar RT (2007) ABPM vs. office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant 11:24-30
15. Mitsnefes MM, Kimball TR, Daniels SR (2003) Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 18:145-149
16. Jacobi J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder RE (2000) Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation 70:819-827
17. Bald M, Bohm W, Feldhoff C, Bonzel KE (2001) Home blood pressure self-measurement in children and adolescents with renal replacement therapy. Klin Padiatr 213:21-25
18. Wühl E, Hadtstein C, Mehls O, Schaefer F; Escape Trial Group (2004) Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 55:492-497
19. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A, Compliance Group of the Spanish Society of Hypertension (2006) Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: The EAPACUM-HTA study. J Hypertens 24:169-175
20. Nagasako SS, Koch Nogueira PC, Machado PGP (2003) Arterial hypertension following renal transplantation in children - a short-term study. Pediatr Nephrol 18:1270-1274
21. Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G, Schärer K (1997) Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 11:23-26
22. Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G (1999) Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 56:1566-1570
23. Giordano U, Matteucci MC, Calzolari A, Turchetta A, Rizzoni G, Alpert BS (2000) Ambulatory blood pressure monitoring in children with aortic coarctation and kidney transplantation. J Pediatr 136:520-523
24. Sorof JM, Poffenbarger T, Portman R (2000) Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis 35:681-686
25. Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Balfe JW (2001) Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 16:843-847
26. Serdaroglu E, Mir S, Berdelli A (2005) Hypertension and ACE gene insertion/deletion polymorphism in pediatric renal transplant patients. Pediatr Transplant 9:612-617
27. Seeman T, Dušek J, Vondrák K, Šimková E, Kreisinger J, Feber J, Janda J (2004) Ambulatory blood pressure monitoring in children after renal transplantation. Transplant Proc 36:1355-1356
28. Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Feber J, Dvorák P, Janda J (2006) Control of hypertension in children after renal transplantation. Pediatr Transplant 10:316-322
29. McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP (2006) Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant 10:558-564
30. Kim HC, Kwon JK, Park SB, Cho WH, Park CH (1998) Hypertension in kidney transplantation recipients: Effect on long-term renal allograft survival. Transplant Proc 30:3906-3907
31. Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A (1993) Hypertension after renal transplantation. Am J Kidney Dis 5(Suppl 2):73-78
32. Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC (1993) The role of hypertension as damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 21(Suppl 1):79-83
33. Seeman T, Palyzova D, Dusek J, Janda J (2005) Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr 147:366-371
34. Morales JM (2002) Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int 62(Suppl):S81-87
35. Lipkin GW, Tucker B, Giles M, Raine AE (1993) Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens 11:439-442
36. Gordjani A, Offner G, Hoyer PF, Brodehl J (1990) Hypertension after renal transplantation in patients treated with cyclosporine and azathioprine. Arch Dis Child 65:275-279
37. Tejani A (1983) Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients. Nephron 34:73-78
38. Budde K, Waiser J, Fritsche L (1997) Hypertension in patients after renal transplantation. Transplant Proc 29:209-211
39. Pérez Fontán M, Rodríguez-Carmona A, Garcia Falcón T, Fernández Rivera C, Valdés F (1999) Early immunological and nonimmunological predictors of arterial hypertension after renal transplantation. Am J Kidney Dis 33:21-25
40. Curtis JJ, Diethelm AG, Jones P, Luke RG, Whelchel JD (1985) Benefits of removal of native kidney in hypertension after renal transplantation. Lancet 2:739-742
41. Vanrenterghem Y, Waer M, Christiaens MR, Michielsen P (1992) Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporine. Leuven Collaborative Group for Transplantation. Transpl Int 5(Suppl 1):S35-37
42. El-Husseini AA, Foda MA, Shokeir AA, Shebab El-Din AB, Sobh MA, Ghoneim MA (2005) Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: A single center experience. Pediatr Transplant 9:763-769
43. Kasiske BL, Ballantyne CM (2002) Cardiovascular risk associated with immunosuppression in renal transplantation. Transplant Rev 16:1-21
44. Inguli E, Tejani A, Markell M (1993) The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era. Transplantation 55:1029-1033
45. Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B (2004) Successful withdrawal of steroids in pediatrics renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: Results after four years. Transplantation 78:228-234
46. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr (2003) Continued superior outcome with modification and lengthened follow-up of a steroid-avoidance pilot with extended Daclizumab induction in pediatric renal transplantation. Transplantation 76:1331-1339
47. Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG (1976) Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol 5:123-127
48. Broyer M, Guest G, Gagnadoux MF, Beurton D (1987) Hypertension following renal transplantation in children. Pediatr Nephrol 1:16-21
49. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT (1987) Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 43:197-204
50. Curtis JJ (1994) Hypertension following kidney transplantation. Am J Kidney Dis 23:471-475
51. Büscher R, Vester U, Wingen AM, Hoyer PF (2004) Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol 19:1202-1211
52. Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 17:141-149
53. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS; FK506 Kidney Transplant Study Group (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63:977-983
54. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J (2002) A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation 73:775-782
55. Margreiter R (2002) Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomized multicentre study. The European Tacrolimus vs Ciclosporin-Microemulsion Renal Transplantation Study Group. Lancet 359:741-746
56. Cheigh JS, Haschemeyer RH, Wang JCL, Riggio RR, Tapia L, Stenzel KH, Rubin AL (1989) Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 2:341-348
57. Fernández-Fresnedo G, Palomar R, Escallada R, Martin de Francisco AL, Cotorruelo JG, Zubimendi JA, Sanz de Castro S, Ruiz JC, Rodrigo E, Arias M (2001) Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate. Nephrol Dial Transplant 16(Suppl 1):105-109
58. Warholm C, Wilczek H, Pettersson E (1995) Hypertension two years after renal transplantation: Causes and consequences. Transpl Int 8:286-292
59. Sorof J, Daniels S (2002) Obesity hypertension in children: A problem of epidemic proportions. Hypertension 40:441-447
60. Lurbe E, Alvarez V, Liao Y, Tacons J, Cooper R, Cremades B, Torro I, Redon J (1998) The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens 11:418-424
61. Hanevold CD, Ho PL, Talley L, Mitsnefes MM (2005) Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 115:352-356
62. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B (1999) The effect of body mass index on long-term renal allograft survival. Transplantation 68:1294-1297
63. Moreso F, Seron D, Anunciada AI, Hueso M, Ramon JM, Fulladosa X, Gil-Vernet S, Alsina J, Grinyo JM (1998) Recipients body surface area as a predictor of post transplant renal allograft evolution. Transplantation 65:671-676
64. Fontaine E, Barthelemy Y, Gagnadoux MF, Cukier J, Broyer M, Beurton D (1994) A review of 72 renal artery stenosis in a series of 715 kidney transplantation in children. Prog Urol 4:193-205
65. Fung LC, McLorie GA, Khoury AR, Churchill BM (1995) Donor aortic cuff reduces the rate of anastomotic arterial stenosis in pediatric renal transplantation. J Urol 154:909-913
66. Bruno S, Remuzzi G, Ruggenenti P (2004) Transplant renal artery stenosis. J Am Soc Nephrol 15:134-141
67. Montagnino G, Tarantino A, Banfi G, Maccario M, Costamagna L, Ponticelli C (2000) Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transpl Int 13:166-168
68. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F (1992) Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 92:375-383
69. Berber I, Aydin C, Yigit B, Kara VM, Yildar M, Duzyol C, Turkmen F, Titiz MI, Altaca G (2005) Blood pressure and graft outcome in renal transplantation. Transplant Proc 37:997-998
70. Akioka K, Takahara S, Ichikawa S, Yoshimura N, Akiyama T, Ohshima S (2005) Factors predicting long-term graft survival after kidney transplantation: Multicenter study in Japan. World J Surg 29:249-256
71. Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Dvorák P, Janda J (2007) Improved control of hypertension in children after renal transplantation: Results of a two-yr interventional trial. Pediatr Transplant 11:491-497
72. Mitsnefes MM, Kimball TR, Border WL, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43:721-726
73. Kitzmueller E, Vécsei A, Pichler J, Bohm M, Muller T, Vargha R, Csaicsich D, Aufricht C (2004) Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 19:1385-1389
74. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal diseases in children: A Dutch cohort study. Kidney Int 61:621-629
75. Ruggenenti P, Perna A, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G (1993) Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 43:706-711
76. Curtis JJ (1997) Treatment of hypertension in renal allograft patients: Does drug selection make a difference. Kidney Int 52(Suppl 63):S75-77
77. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001) Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: A prospective randomized double-blind study. Transplantation 72:107-111
78. Stigant CE, Cohen J, Vivera M, Zaltzman JS (2000) ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy. Am J Kidney Dis 35:58-63
79. Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C (2004) ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol 19:222-226
80. Ruggenenti P, Perna A, Gheradi G, Gaspari F, Benigni R, Remuzzi G (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 352:1352-1356
81. Tejani A, Sullivan EK (2000) The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 4:107-111
82. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF (2004) Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 19:2852-2857
83. Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R (2006) Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17:889-899
84. Opelz G, Zeier M, Laux G, Morath C, Dohler B (2006) No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A Collaborative Transplant Study report. J Am Soc Nephrol 17:3257-3262
85. Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH (1999) ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 33:862-868
86. Calvino J, Lens XM, Romero R, Sánchez-Guisande D (2000) Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant 15:82-86
87. Task force on cardiovascular disease (1998) Special report from the National Kidney Foundation. Am J Kidney Dis 32(Suppl 3):1-121
88. Flynn JT (2006) Hypertension and future cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant 10:276-278
89. Opelz G, Dohler B, Collaborative Transplant Study (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5:2725-2731
90. Groothoff JW, Cransberg K, Offringa M, Van De Kar NJ, Lilien MR, Davin JC, Heymans JS (2004) Long-term follow-up of renal transplantation in children: A Dutch cohort study. Transplantation 78:453-460